Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy.
Pierluigi RussoGiuseppe PalermoRoberto IacovelliRagonese MauroChiara CiccareseGiuseppe MaiorielloFabrizio FantasiaFrancesco Pio BizzarriFilippo MarinoKoosha MoosaviDomenico NigroGiovanni Battista FilomenaFilippo GaviFrancesco RossiFrancesco PintoMarco RacioppiNazario FoschiPublished in: Cancers (2024)
Our study suggests that PIV and SII are two very similar markers that may serve as independent and significant predictors of aggressive disease and worse survival impacts on individuals undergoing radical cystectomy for bladder neoplasm.